跳至主要内容
临床试验/EUCTR2016-003245-29-NL
EUCTR2016-003245-29-NL进行中(未招募)1 期

rsodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass and Sleeve Gastrectomy - UPGRADE

Amsterdam AMC, locatie AMC0 个研究点目标入组 980 人开始时间: 2016年12月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
980

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Scheduled to undergo Roux-en-Y gastric bypass or Sleeve Gastrectomy for morbid obesity
  • An intact gallbladder
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 980
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Symptomatic gallstone disease already present before RYGB or Sleeve Gastrectomy
  • Prior bariatric surgery
  • Prior gallbladder surgery
  • Ascertained or presumptive hypersensitivity to active or excipient ingredients of UDCA.
  • Inflammatory bowel disease and other conditions of the small intestine and liver which may interfere with enterohepatic circulation of bile salts (ileal resection and stoma, extra and intra-hepatic cholestasis, severe liver disease)
  • Intake of investigational drug within the last 30 days before the screening

研究者

发起方
Amsterdam AMC, locatie AMC

相似试验